R M Stone

Port botany container pavements design: construction interface

R M Stone, 1981 .

A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia.

R M Stone, R. Larson, R. Stone, 2000, Blood.

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

R M Stone, R. Larson, H. Dombret, 2008, Leukemia.

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome

R M Stone, D. Neuberg, D. Zahrieh, 2004, Leukemia.

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

R M Stone, S L George, M. Caligiuri, 2011, Leukemia.